Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-4 of 4
1-4 of 4
Filter
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anti-inflammatory, anticoagulant, antipsychotic, appetite, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, bronchodilator, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis industry, cannabis sativa, cannabis strain, cerebellum, certificate of analysis, chemical synapse, chronic condition, chronic fatigue syndrome, depression (mood), diabetes, dispensary, dopamine, dose (biochemistry), dravet syndrome, drug, drug enforcement administration, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, family medicine, fibromyalgia, food and drug administration, free market, gateway drug effect, good manufacturing practice, gpr55, hair loss, heartburn, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medication, medicine, mental disorder, mental health, methotrexate, morphine, national health service, nervous system, norepinephrine, nursing, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, personalized medicine, pharmaceutical industry, pharmacology, pharmacy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, pulmonary fibrosis, randomized controlled trial, residency (medicine), rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, self-medication, serotonin, spasticities, sports medicine, sympathetic nervous system, symptom, synapse, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vagus nerve, vagus nerve stimulation, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
1
1-4 of 4